We first accessed the expression of CD24,CD44v and total CD44 in breast cancer clinical samples through immunofluorescence staining and observed both CD44v+ CSCs (CD24−/CD44+/CD44v+) and CD44v− CSCs (CD24-/CD44+/CD44v−) in tumor tissues. This evidence concerns the gene CD24 and neoplasm.